Literature DB >> 7712740

Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture.

C H Chang1, C P Lin, H Z Wang.   

Abstract

The cell culture method was used to quantitatively evaluate the cytotoxicity to porcine corneal endothelial cells by drugs in the usual concentrations of intracameral injections (ICI). Time-dependent cytotoxicity of drugs was evaluated quantitatively; dye exclusion assay by trypan blue was used as a viability assay; and cytotoxicity to corneal endothelium was tested using amphotericin-B, amikacin, colistin, sulbenicillin, and cephradine in their original, 10-fold, and 100-fold ICI concentrations. Original and 10-fold ICI concentrations of betamethasone also were used. In original and 10-fold ICI concentrations, only amphotericin-B had significant cytotoxicity. In 100-fold ICI concentrations, amphotericin-B, colistin, and sulbenicillin had significant cytotoxicity. Betamethasone had neither a cytotoxic nor a proliferative effect in its original and 10-fold ICI concentrations. A 0.1-fold ICI concentration of amphotericin-B also showed 42.75% cytotoxicity to corneal endothelium by monolayer cultured cells and the time-dependent cytotoxicity of drugs as a quantitative method is efficient and objective.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7712740

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  2 in total

1.  Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.

Authors:  Shinichiro Kobayakawa; Yoshimune Hiratsuka; Yasuo Watabe; Akira Murakami; Tetsuo Tochikubo
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

2.  Successful treatment of Candida albicans anterior chamber infection after penetrating keratoplasty.

Authors:  Spela Stunf Pukl; Azra Herceg; Mojca Globočnik Petrovič; Vladimir Pfeifer
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.